Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (141-150 of 195) with videos related to

Pageof 20
Sort By:
Journal of Oncology Practice|September 1, 2016
Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care DeliveryJulia R Trosman, Ruth C Carlos, Melissa A Simon, et al.
Breast Cancer Research : BCR|October 2, 2023
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
JAMA Network Open|February 26, 2025
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast CancerEmily L Podany, Lorenzo Foffano, Lorenzo Gerratana, et al.
Cancer Letters|November 22, 2024
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profilingLorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Rare Subset of T Cells Form Heterotypic Clusters with Circulating Tumor Cells to Foster Cancer MetastasisDavid Scholten, Lamiaa El-Shennawy, Yuzhi Jia, et al.
Clinical Breast Cancer|August 24, 2017
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast CancerJosé Baselga, Claudio Zamagni, Patricia Gómez, et al.
The Journal of Clinical Investigation|September 16, 2025
Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasisDavid Scholten, Lamiaa El-Shennawy, Yuzhi Jia, et al.
Science Translational Medicine|March 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic valueCarolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana, et al.
JCO Precision Oncology|May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker AnalysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
Neuro-Oncology|August 10, 2022
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokineticsPriya U Kumthekar, Michael J Avram, Andrew B Lassman, et al.
Pageof 20

Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
Journal of Oncology Practice|September 1, 2016
Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care DeliveryJulia R Trosman, Ruth C Carlos, Melissa A Simon, et al.
Breast Cancer Research : BCR|October 2, 2023
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
JAMA Network Open|February 26, 2025
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast CancerEmily L Podany, Lorenzo Foffano, Lorenzo Gerratana, et al.
Cancer Letters|November 22, 2024
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profilingLorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Rare Subset of T Cells Form Heterotypic Clusters with Circulating Tumor Cells to Foster Cancer MetastasisDavid Scholten, Lamiaa El-Shennawy, Yuzhi Jia, et al.
Clinical Breast Cancer|August 24, 2017
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast CancerJosé Baselga, Claudio Zamagni, Patricia Gómez, et al.
The Journal of Clinical Investigation|September 16, 2025
Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasisDavid Scholten, Lamiaa El-Shennawy, Yuzhi Jia, et al.
Science Translational Medicine|March 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic valueCarolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana, et al.
JCO Precision Oncology|May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker AnalysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
Neuro-Oncology|August 10, 2022
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokineticsPriya U Kumthekar, Michael J Avram, Andrew B Lassman, et al.
Pageof 20